Literature DB >> 2515602

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee.

B M Farr1, D L Kaiser, B D Harrison, C K Connolly.   

Abstract

The selection of initial antimicrobial treatment in a patient with community acquired pneumonia is an important clinical decision. Because this decision is usually made before the results of specific microbiological tests are available, we attempted to determine how well the presenting clinical features would allow prediction of microbial aetiology in 441 adults admitted to hospital with pneumonia. Five of 90 variable available on admission were selected for inclusion in a multivariate discriminant function analysis because of their strong association with one or more of the major aetiological subsets (Mycoplasma pneumoniae, Streptococcus pneumoniae, "other," and undetermined). These variables were age, number of days ill before admission, presence or absence of bloody sputum and of lobar infiltration on chest radiograph, and white blood cell count. The microbial aetiology was correctly predicted by this discriminant function analysis in only 42% of cases, which gives a quantitative estimate of the degree of difficulty encountered in determining the microbial aetiology at the time of admission for pneumonia. When a similar discriminant function analysis was applied to the third of patients in whom the microbial aetiology was never determined, most of these cases were predicted to be due to Streptococcus pneumoniae.

Entities:  

Mesh:

Year:  1989        PMID: 2515602      PMCID: PMC1020880          DOI: 10.1136/thx.44.12.1031

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  The triple threat of aspiration pneumonia.

Authors:  J G Bartlett; S L Gorbach
Journal:  Chest       Date:  1975-10       Impact factor: 9.410

2.  PNEUMONIA IN HOSPITAL PRACTICE IN EDINBURGH 1960-1962.

Authors:  J C BATH; G P BOISSARD; M A CALDER; M A MOFFAT
Journal:  Br J Dis Chest       Date:  1964-01

3.  Counter-current immunoelectrophoresis for the diagnosis of pneumococcal chest infection.

Authors:  M El-Refaie; C Dulake
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

4.  Effect of previous antimicrobial therapy on bacteriological findings in patients with primary pneumonia.

Authors:  R C Spencer; J R Philp
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

5.  A micro-capture ELISA for detecting Mycoplasma pneumoniae IgM: comparison with indirect immunofluorescence and indirect ELISA.

Authors:  T G Wreghitt; M Sillis
Journal:  J Hyg (Lond)       Date:  1985-04

6.  Accuracy of Gram's stain in identifying pneumococci in sputum.

Authors:  M F Rein; J M Gwaltney; W M O'Brien; R H Jennings; G L Mandell
Journal:  JAMA       Date:  1978-06-23       Impact factor: 56.272

7.  Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias.

Authors:  M A Woodhead; J T Macfarlane
Journal:  Br J Dis Chest       Date:  1987-04
  7 in total
  32 in total

1.  Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study.

Authors:  M L Lorente; M Falguera; A Nogués; A R González; M T Merino; M R Caballero
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment.

Authors:  A Willy Graffelman; Arie Knuistingh Neven; Saskia le Cessie; Aloys C M Kroes; Machiel P Springer; Peterhans J van den Broek
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

Review 4.  Community acquired pneumonia: assessment and treatment.

Authors:  Caroline M Patterson; Michael R Loebinger
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Can J Infect Dis       Date:  2000-09

7.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 8.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

9.  Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia.

Authors:  R Bohte; J Hermans; P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

10.  Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.

Authors:  J Gómez; V Baños; J Ruiz Gómez; M C Soto; L Muñoz; M L Nuñez; M Canteras; M Valdés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.